BAYER AG
π©πͺGermany
- Country
- π©πͺGermany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Sun Protection Factor Assay (SPF Assay 200/2016)
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: BAY987516
- First Posted Date
- 2016-10-12
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 3
- Registration Number
- NCT02930759
Sun Protection Factor Assay (SPF Assay 201/2016)
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: BAY987516
- First Posted Date
- 2016-10-12
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 11
- Registration Number
- NCT02930772
Sun Protection Factor Assay (SPF Assay 203/2016)
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: BAY987516
- First Posted Date
- 2016-10-12
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 3
- Registration Number
- NCT02930798
Sun Protection Factor Assay (SPF Assay 199/2016)
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: BAY987516
- First Posted Date
- 2016-10-12
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 3
- Registration Number
- NCT02930746
Sun Protection Factor Assay (SPF Assay 202/2016)
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: BAY987517
- First Posted Date
- 2016-10-12
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 5
- Registration Number
- NCT02930785
Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma
Phase 1
Terminated
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2016-10-07
- Last Posted Date
- 2020-02-26
- Lead Sponsor
- Bayer
- Target Recruit Count
- 7
- Registration Number
- NCT02928029
- Locations
- πΊπΈ
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States
πΊπΈPacific Oncology/Hematology Associates, Encinitas, California, United States
π°π·Seoul National University Hospital, Seoul, Korea, Republic of
Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular Edema
Completed
- Conditions
- Diabetic Retinopathy
- Interventions
- First Posted Date
- 2016-10-05
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Bayer
- Target Recruit Count
- 402
- Registration Number
- NCT02924311
A Cross-sectional, Observational Multicenter Study to Assess the Reasons for Choosing the 3-year Hormonal IUD and Level of IUDs Knowledge Among Women Aged 18 to 29 Years
Completed
- Conditions
- Intrauterine Devices, Medicated
- Interventions
- First Posted Date
- 2016-09-16
- Last Posted Date
- 2018-01-12
- Lead Sponsor
- Bayer
- Target Recruit Count
- 886
- Registration Number
- NCT02903888
Navigant Study- Treatment Patterns in mCRPC (Metastatic Castrate Resistant Prostate Cancer )
Completed
- Conditions
- Prostatic Neoplasms, Castration-Resistant
- Interventions
- First Posted Date
- 2016-09-14
- Last Posted Date
- 2020-03-31
- Lead Sponsor
- Bayer
- Target Recruit Count
- 200
- Registration Number
- NCT02899104
- Locations
- πΊπΈ
Whippany, Whippany, New Jersey, United States
Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision Algorithm
Withdrawn
- Conditions
- Atrial FibrillationVenous ThromboembolismPulmonary Embolism
- Interventions
- Other: XAPPORTOther: Expert Panel ("gold standard")
- First Posted Date
- 2016-09-14
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Bayer
- Registration Number
- NCT02900404
Β© Copyright 2025. All Rights Reserved by MedPath